Astera Labs, Inc. $ALAB Stake Boosted by Diversified Trust Co

Diversified Trust Co lifted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 62.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,369 shares of the company’s stock after purchasing an additional 1,685 shares during the quarter. Diversified Trust Co’s holdings in Astera Labs were worth $479,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. acquired a new position in shares of Astera Labs during the fourth quarter valued at $18,708,000. Nordea Investment Management AB bought a new position in shares of Astera Labs during the fourth quarter worth about $2,028,000. Geneva Partners LLC acquired a new stake in shares of Astera Labs in the 3rd quarter worth about $1,876,000. Swedbank AB increased its holdings in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares during the period. Finally, Numerai GP LLC lifted its position in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on ALAB. JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Needham & Company LLC raised their price target on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Evercore reaffirmed an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Loop Capital assumed coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective for the company. Finally, Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $254.75.

Insider Transactions at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the transaction, the director directly owned 60,134 shares in the company, valued at approximately $21,909,822.90. This trade represents a 5.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the transaction, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,161,256 shares of company stock valued at $459,844,296 over the last three months. 10.40% of the stock is owned by company insiders.

Astera Labs Trading Down 0.5%

ALAB stock opened at $398.00 on Friday. Astera Labs, Inc. has a 52 week low of $85.85 and a 52 week high of $440.99. The company has a market capitalization of $68.22 billion, a price-to-earnings ratio of 268.92, a price-to-earnings-growth ratio of 4.59 and a beta of 3.95. The firm’s 50-day moving average is $284.80 and its two-hundred day moving average is $194.71.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the firm posted $0.33 earnings per share. The business’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.